C9ORF72

Chr 9AD

C9orf72-SMCR8 complex subunit

Also known as: ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1

The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]

GeneReviewsOMIMResearchGenerating clinical summary…
ADLOEUF 0.931 OMIM phenotype
Clinical SummaryC9ORF72
🧬
Gene-Disease Validity (ClinGen)
frontotemporal dementia and/or amyotrophic lateral sclerosis 1 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
3 unique Pathogenic / Likely Pathogenic· 51 VUS of 104 total submissions
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — C9ORF72
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.93LOEUF
pLI 0.000
Z-score 1.82
OE 0.58 (0.380.93)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.24Z-score
OE missense 0.96 (0.861.06)
240 obs / 250.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.58 (0.380.93)
00.351.4
Missense OE?0.96 (0.861.06)
00.61.4
Synonymous OE?1.16
01.21.6
LoF obs/exp: 13 / 22.3Missense obs/exp: 240 / 250.9Syn Z: -1.20

ClinVar Variant Classifications

104 submitted variants in ClinVar

Classification Summary

Pathogenic3
VUS51
Likely Benign8
Benign23
3
Pathogenic
51
VUS
8
Likely Benign
23
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
3
0
3
Likely Pathogenic
0
0
0
0
0
VUS
1
15
31
4
51
Likely Benign
0
2
3
3
8
Benign
0
1
17
5
23
Total118541285

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

73 pathogenic / likely-pathogenic (of 83) ClinVar copy-number / structural variants overlap C9ORF72 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

C9ORF72 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Frontotemporal Dementia

GENetic Fronto Temporal Dementia Initiative in Lille

RECRUITING
NCT04639622Phase NAUniversity Hospital, LilleStarted 2019-04-23
Investigation procedures
Amyotrophic Lateral Sclerosis (ALS)

Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study

RECRUITING
NCT06681610Phase NAParc de Salut MarStarted 2024-10-24
Transcranial Pulse Stimulation
Frontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

RECRUITING
NCT04363684Mayo ClinicStarted 2020-03-01
Frontotemporal DementiaFamily Members

Genetic Frontotemporal Dementia Initiative for Neurodevelopment

RECRUITING
NCT05779813Western UniversityStarted 2023-03-31
ALS (Amyotrophic Lateral Sclerosis)

Amyotrophic Lateral Sclerosis Registry in Thailand

RECRUITING
NCT07175935Chulalongkorn UniversityStarted 2025-03-01
Frontotemporal DementiaFrontotemporal Lobar DegenerationFTD-GRN

Neurofilament Surveillance Project (NSP)

ACTIVE NOT RECRUITING
NCT04516499The Bluefield Project to Cure Frontotemporal DementiaStarted 2020-09-02
Amyotrophic Lateral Sclerosis

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

RECRUITING
NCT00317616University of MiamiStarted 2006-04
Amyotrophic Lateral SclerosisMotor Neuron Disease

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

ACTIVE NOT RECRUITING
NCT07204977Phase PHASE1National Institute of Neurological Disorders and Stroke (NINDS)Started 2026-02-02
Acamprosate calcium
Amyotrophic Lateral Sclerosis

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

ACTIVE NOT RECRUITING
NCT05633459Phase PHASE1QurAlis CorporationStarted 2022-12-16
Multiple ascending doses of QRL-201Multiple ascending doses of PlaceboQRL-201
ALS

Amyotrophic Lateral Sclerosis (ALS) Families Project

RECRUITING
NCT03865420Columbia UniversityStarted 2018-09-11
Corticobasal Syndrome(CBS)Primary Progressive Aphasia(PPA)Progressive Supranuclear Palsy(PSP)

Neuroinflammation in FTLD

ACTIVE NOT RECRUITING
NCT06870838Leiden University Medical CenterStarted 2023-07-25
7T MRI scanCSFBlood withdrawal
Neurodegenerative DiseasesDementia

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

RECRUITING
NCT06339190Monash UniversityStarted 2021-08-01
Venepuncture